[ad_1]
San Francisco, May 12, 2021 /PRNewswire/-Global Advanced Therapy Drug Market The size is expected to reach 21 USDAccording to the latest report of Grand View Research, Inc, it will reach 20 million by 2028. From 2021 to 2028, the market is expected to grow at a compound annual growth rate of 13.2%. Solve the root cause, not treat the symptoms. Therefore, ATMP helps provide transformative advantages that traditional treatment methods cannot provide. These factors are expected to drive the market during the forecast period.
The main recommendations in the report:
- The cell therapy segment will account for the largest revenue share in 2020 due to the large number of approved products in this segment
- Increased investment flows to sponsor clinical trials have also stimulated revenue share in the field of cell therapy
- The introduction of effective guidelines to support the production of cell therapies and the recently approved advanced therapies further contribute to the dominance of the field
- Geographical expansion of Yescarta and Kymriah Japan with Europe Encourage investors to support the development of this field
- The latest approval of gene therapy has greatly accelerated clinical trials in this field
- The COVID-19 pandemic opens up new areas for major players to invest in T cell research for viral infections
- The research community is actively evaluating the potential of advanced therapies in COVID-19 patients, thereby contributing to market growth
- North America Due to the exponential growth of clinical trials related to advanced therapies, it will account for the largest revenue share in 2020
- U.S. strong ATMP channel accelerates revenue generation in the region
- In addition, the focus of U.S. companies has shifted from traditional drug development to ATMPS, which is driving regional growth
- in Asia-Pacific, Due to ATMP’s presence in emerging markets (e.g., China At the forefront
- Expand business ChinaCDMO drives the growth of the regional market
- Key companies are taking various strategic measures to maintain their market position. Cooperation between ViGeneron GmbH and Biogen Inc. January 2021 Is one of the notable examples of cooperation in this field
- The two companies collaborated to develop AAV-based gene therapy products for the treatment of hereditary eye diseases
Read the 225-page research report with ToC, which covers the “Advanced Therapeutic Drug Market Scale, Regional Share and Trend Analysis Report by Treatment Type (CAR-T, Gene, Cell, Stem Cell Therapy)”North America, Europe, APAC, ROW) and audience segment forecasts, 2021-2028″ located at: https://www.grandviewresearch.com/industry-analysis/advanced-therapy-medicinal-products-market
The breakthrough approvals obtained by Tecartus and Abecma after obtaining Zolgensma, Kymriah and Yescarta approvals have promoted extraordinary progress in this field. These approvals stimulated the flow of investment in this area, thereby driving revenue growth. Key companies are adopting various operating models to speed up the product manufacturing process.
In addition, the market has witnessed acquisitions by some participants who intend to enter or expand their existing businesses in this field. Gilead Life Science’s acquisition of Kite Pharma, Novartis’s acquisition of AveXis and Celgene’s acquisition of Juno Therapeutics are some of the major recent examples. These acquisitions illustrate the growing interest of mature pharmaceutical companies in this market. Increasing competition for gene therapy acquisitions may result in huge premiums.
On the other hand, with the growth of consumer demand, ATMP manufacturers outsource the manufacturing of their products, thus creating rich opportunities for contract manufacturing organizations. Therefore, some CDMOs have expanded their facilities.For example, in January 2021, FUJIFILM Diosynth Biotechnologies invested 40 million USD Establish new process development and production facilities for advanced therapies and viral vectors.
According to treatment types and regions, Grand View Research has segmented the global advanced therapeutic drug product market:
- Outlook for ATMP treatment types (income, million dollars, 2017-2028)
- Cell therapy
- Gene therapy
- CAR-T therapy
- Tissue Engineering Products
- ATMP Regional Outlook (Revenue, USD Million, 2017-2028)
- North America
- Europe
- Asia-Pacific
- China
- Japan
- Russia
- Australia
- India
- Rest of the world
List of major players in the Advanced Therapeutic Products (ATMPs) market
- Novartis
- Gilead Sciences
- TCR2 Therapeutics Inc
- Bluebird Bio
- New base company
- Spark therapy
- Kolon TissueGene, Inc.
- Pharmaceutical Co., Ltd
- Postman
- JCR Pharmaceuticals Co., Ltd.
- Vericel Corporation
- Organogenesis company
Find more research reports on Pharmaceutical Industry, Written by Grand View Research:
- Cell and gene therapy clinical trial market-The global cell and gene therapy clinical trial market is expected to reach US$45.4 billion According to a new report from Grand View Research, Inc., by 2028. It is estimated that from 2021 to 2028, CAGR will grow at a compound annual growth rate of 22.3%.
- Oxygen Therapy Market-The global oxygen therapy market is expected to reach $18.2 billion According to a new study by Grand View Research, Inc., by 2024.
- Hormone Replacement Therapy Market-The global hormone replacement therapy market is expected to reach $39.6 billion According to the latest report of Grand View Research, Inc., by 2027, the compound annual growth rate will reach 7.7%.
Get access Grand compass, Our BI-supported intuitive market research database contains more than 10,000 reports
About Grand View Research
Grand View Research, a US market research and consulting company, provides syndicated and customized research reports and consulting services.Registered at California Headquartered in San FranciscoThe company is composed of more than 425 analysts and consultants, adding more than 1,200 market research reports to its huge database every year. These reports provide in-depth analysis of 46 industries in 25 major countries/regions around the world. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and well-known academic institutions understand the global and regional business environment and seize future opportunities.
contact:
Sherry James
Corporate Sales Specialist, United States
Grand View Research, Inc.
Phone: + 1-415-349-0058
Toll Free: 1-888-202-9519
e-mail: sales@grandviewresearch.com
Web page: https://www.grandviewresearch.com
follow us: LinkedIn | Twitter
View original content:http://www.prnewswire.com/news-releases/advanced-therapy-medicinal-products-market-size-worth-21-2-billion-by-2028-grand-view-research-inc-301289410.html
SOURCE Grand View Research, Inc.
[ad_2]
Source link
